EPAS1 and breast cancer: While HIF-2α expression has also been associated with high ABCG2 expression, histology-grade and Ki67 expression in invasive human breast cancer, suggesting that HIF-2α could be a reliable prognostic marker for development of drug resistance and metastasis in breast cancer [22].